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suggested by Prof. Fourtonunas. The number and the cause of
infections are shown in Table 1. Sufﬁce to say that there were
no statistical differences in peritonitis rates caused by
‘virulent’ organisms, although the lack of power of such an
analysis needs to be reiterated.
We thank Prof. Fourtounas for his interest in our study
and the discussion that has ensued from his pertinent
observations.
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Chronic kidney disease in
Pakistan: an under-recognized
public health problem
To the Editor: We read with interest Couser et al.’s1 article,
which highlighted the global burden of chronic kidney disease
(CKD) and its inequitable distribution among developing
countries. In a survey conducted in 2011 in Karachi, a city
harboring 9% of Pakistan’s population, where we looked at
serum creatinine of 300 adults 30 years or older from the
community, an astonishing 25.3% had some degree of
reduced glomerular ﬁltration rate (GFR), with 5% having
moderate CKD (GFR o60ml/min).2 Even more disturbing
was the fact that only 2.3% individuals were aware of having
renal disease, most people with lower income falling in to this
category. In this subset, 20% had coexistent diabetes, 65% had
HTN, and 10% had both conditions. Extrapolation of these
ﬁndings translates to 12.86 million Pakistanis above 30 years
of age having some degree of renal impairment, which is
representative of a huge disease burden.
With rampant lack of awareness in developing countries,
there is underdetection of earlier stages of CKD, leading to
lack of preventive measures, which inevitably facilitates
progression of mild, potentially treatable CKD to full-blown
kidney failure. Where the annual cost of dialysis of a single
patient is over $3000, annual per capita income is $1200, and
spending on health is a meager 0.23% of the gross national
product, it is not surprising that although the incidence of
end-stage renal disease is estimated to be between 34 and 240
per million people, only 10% receive any renal replacement
therapy.3 The dire need of international programs aimed at
preventing and controlling CKD in third-world countries
such as Pakistan cannot be stressed on enough.
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The Authors Reply: We thank Drs Saeed and Hussain1 for
providing these interesting data about chronic kidney disease
(CKD) in Karachi, Pakistan, and conﬁrming again the high
burden and very low awareness of CKD in an urban devel-
oping country setting. We hope our paper, which prompted
the letter,2 and additional information like this from Pakistan
and other countries, will contribute to expanding awareness
of CKD as a major global health problem.
We agree completely with Dr Saeed that ‘international
programs aimed at prevention and control of CKD in third-
world countries’ are indeed badly needed and represent the
only economically feasible approach to the long-term reduc-
tion of CKD and its consequences, including both cardiovas-
cular disease and end-stage renal disease. We are encouraged
that the political declaration of the recent High-Level Meeting
of the United Nations General Assembly on the Prevention
and Control of Non-Communicable Diseases identiﬁed renal
diseases for the ﬁrst time as posing a major health burden for
many countries and acknowledged that these diseases share
common risk factors with other non-communicable diseases
and can beneﬁt from common responses.3 We hope our
efforts and those of the International Society of Nephrology4
have contributed to ﬁnally getting kidney disease a place on
the global health agenda. We call on all of our colleagues in
the international renal community to continue efforts such as
those of Drs Saeed and Hussain to document and increase
awareness of CKD and to translate these advances to tangible
changes in public health policy that will beneﬁt all kidney
patients in the future.
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U-shaped effect of eGFR and
mortality
To the Editor: Recently, Tonelli et al.1 presented interesting
data on the association of estimated glomerular ﬁltration rate
(eGFR) values with an increased all-cause and cerebrovas-
cular mortality in a Canadian population over a median period
of 35 months. They postulated various reasons to account for
this, including inadequacies of the eGFR value at low serum
creatinine concentrations.
In this regard, we would like to share similar ﬁndings with
our work about 3 years ago in which we ﬁrst demonstrated a
U-shaped effect of eGFR and mortality in a cohort of UK
community-based patients (n¼ 33,386; 18,620 female and
14,766 male) over 50 years of age (median 68 years; inter-
quartile range 60–76 years).2 These patients were classiﬁed
according to their eGFR values (o30, 30–59, 60–89, 90–119,
and 120–150ml/min per 1.73m2). By applying Cox propor-
tional hazards models (adjusted for age and gender), we
found that the hazard ratio (HR) of dying compared with a
reference of patients with eGFRs of 60–89ml/min per 1.73m2
was, as anticipated, higher in the low eGFR bands with a HR
of 1.37 (95% conﬁdence interval (CI) 1.29–1.45) for 30–59ml/
min per 1.73m2 and a HR of 2.60 (95% CI 2.31–2.93) for
o30ml/min per 1.73m2. However, we also found a higher
mortality for higher eGFRs with a HR of 1.29 (1.19–1.41) for
90–119ml/min per 1.73m2 and a HR of 2.63 (2.16–3.21) for
120–150ml/min per 1.73m2 (Figure 1). Our data suggested
that men were more at risk and circulatory disease was the
main cause of death in patients with low eGFR values. In
contrast, we noted that respiratory disease and cancer seemed
to be more prevalent as a cause of death in patients with high
eGFR values. Although there are limitations to our study, the
paper from Tonelli et al. would seem to, in part, verify and
support our ﬁndings of adverse outcomes at higher eGFR
values. The current chronic kidney disease guidelines that
recommend inaction or even the non-reporting of eGFR
values greater than 60–90ml/min per 1.73m2 may not identify
patients who are at an equally high risk of dying as those in
whom intervention is recommended. This may need further
consideration and reevaluation to ensure that correct advice is
given to primary care physicians and patients.
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Figure 1 |Age- and gender-adjusted hazard ratios for death
(þ 95% CI) compared with an estimated glomerular filtration
rate (eGFR) of 60–89ml/min per 1.73m2 (n¼ 33,386);
*Po0.0001.
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